Pregabalin immediate release, 300 mg
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions
Healthy
Phase 1
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers
CompletedNCT01257516
Start: 2011-02-28End: 2011-03-31Updated: 2021-01-22
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
CompletedNCT01257529
Start: 2011-03-31End: 2011-04-30Updated: 2021-01-22
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
CompletedNCT01270815
Start: 2011-03-31End: 2011-04-30Updated: 2021-01-22
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
CompletedNCT01291524
Start: 2011-02-28End: 2011-05-31Updated: 2021-01-22
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
CompletedNCT01321671
Start: 2011-04-30End: 2011-06-30Updated: 2021-01-22